{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T02:57:53Z","timestamp":1788577073182,"version":"build-2803163510"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:00:00Z","timestamp":1667001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["T32-CA009111"],"award-info":[{"award-number":["T32-CA009111"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F31-AI149866"],"award-info":[{"award-number":["F31-AI149866"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R24GM137782-01"],"award-info":[{"award-number":["R24GM137782-01"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"United States Department of Defense | Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["HR00111920008"],"award-info":[{"award-number":["HR00111920008"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Communicable respiratory viral infections pose both epidemic and pandemic threats and broad-spectrum antiviral strategies could improve preparedness for these events. To discover host antiviral restriction factors that may act as suitable targets for the development of host-directed antiviral therapies, we here conduct a whole-genome CRISPR activation screen with influenza B virus (IBV). A top hit from our screen, beta-1,3-glucuronyltransferase 1 (B3GAT1), effectively blocks IBV infection. Subsequent studies reveal that B3GAT1 activity prevents cell surface sialic acid expression. Due to this mechanism of action, B3GAT1 expression broadly restricts infection with viruses that require sialic acid for entry, including Victoria and Yamagata lineage IBVs, H1N1\/H3N2 influenza A viruses (IAVs), and the unrelated enterovirus D68. To understand the potential utility of B3GAT1 induction as an antiviral strategy in vivo, we specifically express B3GAT1 in the murine respiratory epithelium and find that overexpression is not only well-tolerated, but also protects female mice from a lethal viral challenge with multiple influenza viruses, including a pandemic-like H1N1 IAV. Thus, B3GAT1 may represent a host-directed broad-spectrum antiviral target with utility against clinically relevant respiratory viruses.<\/jats:p>","DOI":"10.1038\/s41467-022-34111-0","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T08:03:10Z","timestamp":1667030590000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cellular glycan modification by B3GAT1 broadly restricts influenza virus infection"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5463-7144","authenticated-orcid":false,"given":"Joseph D.","family":"Trimarco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan R.","family":"Chaparian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8178-0376","authenticated-orcid":false,"given":"Alexandra I.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0685-722X","authenticated-orcid":false,"given":"Nathan B.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parastoo","family":"Azadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1884-6309","authenticated-orcid":false,"given":"Carolyn B.","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5307-3428","authenticated-orcid":false,"given":"Nicholas S.","family":"Heaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,29]]},"reference":[{"key":"34111_CR1","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","author":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators.","year":"2018","unstructured":"GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789\u20131858 (2018).","journal-title":"Lancet"},{"key":"34111_CR2","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","volume":"392","author":"GBD 2017 Causes of Death Collaborators.","year":"2018","unstructured":"GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1736\u20131788 (2018).","journal-title":"Lancet"},{"key":"34111_CR3","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1093\/femsre\/fuv039","volume":"40","author":"M Richard","year":"2016","unstructured":"Richard, M. & Fouchier, R. A. Influenza A virus transmission via respiratory aerosols or droplets as it relates to pandemic potential. FEMS Microbiol. Rev. 40, 68\u201385 (2016).","journal-title":"FEMS Microbiol. Rev."},{"key":"34111_CR4","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/s41579-021-00535-6","volume":"19","author":"NHL Leung","year":"2021","unstructured":"Leung, N. H. L. Transmissibility and transmission of respiratory viruses. Nat. Rev. Microbiol. 19, 528\u2013545 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"34111_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","volume":"17","author":"K Houser","year":"2015","unstructured":"Houser, K. & Subbarao, K. Influenza vaccines: challenges and solutions. Cell Host Microbe 17, 295\u2013300 (2015).","journal-title":"Cell Host Microbe"},{"key":"34111_CR6","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1093\/cid\/ciaa1432","volume":"72","author":"AM Lerner","year":"2021","unstructured":"Lerner, A. M. et al. Unraveling the mysteries of acute flaccid myelitis: scientific opportunities and priorities for future research. Clin. Infect. Dis. 72, 2044\u20132048 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"34111_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","volume":"27","author":"JL Excler","year":"2021","unstructured":"Excler, J. L., Saville, M., Berkley, S. & Kim, J. H. Vaccine development for emerging infectious diseases. Nat. Med. 27, 591\u2013600 (2021).","journal-title":"Nat. Med."},{"key":"34111_CR8","unstructured":"United States Food and Drug Administration. Influenza (Flu) Antiviral Drugs and Related Information, <https:\/\/www.fda.gov\/drugs\/information-drug-class\/influenza-flu-antiviral-drugs-and-related-information> (2020)."},{"key":"34111_CR9","doi-asserted-by":"publisher","unstructured":"Kumar, N. et al. Host-directed antiviral therapy. Clin. Microbiol. Rev. 33, https:\/\/doi.org\/10.1128\/CMR.00168-19 (2020).","DOI":"10.1128\/CMR.00168-19"},{"key":"34111_CR10","doi-asserted-by":"publisher","first-page":"vew014","DOI":"10.1093\/ve\/vew014","volume":"2","author":"KK Irwin","year":"2016","unstructured":"Irwin, K. K., Renzette, N., Kowalik, T. F. & Jensen, J. D. Antiviral drug resistance as an adaptive process. Virus Evol. 2, vew014 (2016).","journal-title":"Virus Evol."},{"key":"34111_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2147\/IDR.S105473","volume":"10","author":"M Hussain","year":"2017","unstructured":"Hussain, M., Galvin, H. D., Haw, T. Y., Nutsford, A. N. & Husain, M. Drug resistance in influenza A virus: the epidemiology and management. Infect. Drug Resist 10, 121\u2013134 (2017).","journal-title":"Infect. Drug Resist"},{"key":"34111_CR12","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.celrep.2017.07.060","volume":"20","author":"BE Heaton","year":"2017","unstructured":"Heaton, B. E. et al. A CRISPR activation screen identifies a pan-avian influenza virus inhibitory host factor. Cell Rep. 20, 1503\u20131512 (2017).","journal-title":"Cell Rep."},{"key":"34111_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cell.2020.12.005","volume":"184","author":"HH Hoffmann","year":"2021","unstructured":"Hoffmann, H. H. et al. TMEM41B is a pan-flavivirus host factor. Cell 184, 133\u2013148.e120 (2021).","journal-title":"Cell"},{"key":"34111_CR14","doi-asserted-by":"publisher","first-page":"e1009599","DOI":"10.1371\/journal.ppat.1009599","volume":"17","author":"JD Trimarco","year":"2021","unstructured":"Trimarco, J. D. et al. TMEM41B is a host factor required for the replication of diverse coronaviruses including SARS-CoV-2. PLoS Pathog. 17, e1009599 (2021).","journal-title":"PLoS Pathog."},{"key":"34111_CR15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.celrep.2018.03.045","volume":"23","author":"J Han","year":"2018","unstructured":"Han, J. et al. Genome-wide CRISPR\/Cas9 screen identifies host factors essential for influenza virus replication. Cell Rep. 23, 596\u2013607 (2018).","journal-title":"Cell Rep."},{"key":"34111_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cell.2020.12.006","volume":"184","author":"WM Schneider","year":"2021","unstructured":"Schneider, W. M. et al. Genome-scale identification of SARS-CoV-2 and pan-coronavirus host factor networks. Cell 184, 120\u2013132.e114 (2021).","journal-title":"Cell"},{"key":"34111_CR17","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.celrep.2015.06.049","volume":"12","author":"H Ma","year":"2015","unstructured":"Ma, H. et al. A CRISPR-based screen identifies genes essential for West-Nile-virus-induced cell death. Cell Rep. 12, 673\u2013683 (2015).","journal-title":"Cell Rep."},{"key":"34111_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/nature18631","volume":"535","author":"CD Marceau","year":"2016","unstructured":"Marceau, C. D. et al. Genetic dissection of Flaviviridae host factors through genome-scale CRISPR screens. Nature 535, 159\u2013163 (2016).","journal-title":"Nature"},{"key":"34111_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/nature18625","volume":"535","author":"R Zhang","year":"2016","unstructured":"Zhang, R. et al. A CRISPR screen defines a signal peptide processing pathway required by flaviviruses. Nature 535, 164\u2013168 (2016).","journal-title":"Nature"},{"key":"34111_CR20","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nrmicro.2017.29","volume":"15","author":"AS Puschnik","year":"2017","unstructured":"Puschnik, A. S., Majzoub, K., Ooi, Y. S. & Carette, J. E. A CRISPR toolbox to study virus-host interactions. Nat. Rev. Microbiol. 15, 351\u2013364 (2017).","journal-title":"Nat. Rev. Microbiol."},{"key":"34111_CR21","doi-asserted-by":"publisher","unstructured":"Dukhovny, A. et al. A CRISPR activation screen identifies genes that protect against Zika virus infection. J. Virol. 93, https:\/\/doi.org\/10.1128\/JVI.00211-19 (2019).","DOI":"10.1128\/JVI.00211-19"},{"key":"34111_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13965-x","volume":"11","author":"B Li","year":"2020","unstructured":"Li, B. et al. Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection. Nat. Commun. 11, 164 (2020).","journal-title":"Nat. Commun."},{"key":"34111_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21213-4","volume":"12","author":"Y Zhu","year":"2021","unstructured":"Zhu, Y. et al. A genome-wide CRISPR screen identifies host factors that regulate SARS-CoV-2 entry. Nat. Commun. 12, 961 (2021).","journal-title":"Nat. Commun."},{"key":"34111_CR24","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.cell.2020.10.028","volume":"184","author":"J Wei","year":"2021","unstructured":"Wei, J. et al. Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection. Cell 184, 76\u201391 e13 (2021).","journal-title":"Cell"},{"key":"34111_CR25","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41588-021-00805-2","volume":"53","author":"J Baggen","year":"2021","unstructured":"Baggen, J. et al. Genome-wide CRISPR screening identifies TMEM106B as a proviral host factor for SARS-CoV-2. Nat. Genet. 53, 435\u2013444 (2021).","journal-title":"Nat. Genet."},{"key":"34111_CR26","doi-asserted-by":"publisher","first-page":"e1007601","DOI":"10.1371\/journal.ppat.1007601","volume":"15","author":"M Lesch","year":"2019","unstructured":"Lesch, M. et al. RNAi-based small molecule repositioning reveals clinically approved urea-based kinase inhibitors as broadly active antivirals. PLoS Pathog. 15, e1007601 (2019).","journal-title":"PLoS Pathog."},{"key":"34111_CR27","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.chom.2015.11.002","volume":"18","author":"S Tripathi","year":"2015","unstructured":"Tripathi, S. et al. Meta- and orthogonal integration of influenza \u201cOMICs\u201d data defines a role for UBR4 in virus budding. Cell Host Microbe 18, 723\u2013735 (2015).","journal-title":"Cell Host Microbe"},{"key":"34111_CR28","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.celrep.2015.05.032","volume":"11","author":"AA Benitez","year":"2015","unstructured":"Benitez, A. A. et al. In vivo RNAi screening identifies MDA5 as a significant contributor to the cellular defense against influenza A virus. Cell Rep. 11, 1714\u20131726 (2015).","journal-title":"Cell Rep."},{"key":"34111_CR29","doi-asserted-by":"publisher","first-page":"17516","DOI":"10.1073\/pnas.1312374110","volume":"110","author":"WC Su","year":"2013","unstructured":"Su, W. C. et al. Pooled RNAi screen identifies ubiquitin ligase Itch as crucial for influenza A virus release from the endosome during virus entry. Proc. Natl Acad. Sci. USA 110, 17516\u201317521 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34111_CR30","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1038\/nature08760","volume":"463","author":"A Karlas","year":"2010","unstructured":"Karlas, A. et al. Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication. Nature 463, 818\u2013822 (2010).","journal-title":"Nature"},{"key":"34111_CR31","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1038\/nature07151","volume":"454","author":"L Hao","year":"2008","unstructured":"Hao, L. et al. Drosophila RNAi screen identifies host genes important for influenza virus replication. Nature 454, 890\u2013893 (2008).","journal-title":"Nature"},{"key":"34111_CR32","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nature12862","volume":"505","author":"JW Schoggins","year":"2014","unstructured":"Schoggins, J. W. et al. Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature 505, 691\u2013695 (2014).","journal-title":"Nature"},{"key":"34111_CR33","first-page":"1","volume":"367","author":"M Matrosovich","year":"2015","unstructured":"Matrosovich, M., Herrler, G. & Klenk, H. D. Sialic acid receptors of viruses. Top. Curr. Chem. 367, 1\u201328 (2015).","journal-title":"Top. Curr. Chem."},{"key":"34111_CR34","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1111\/tra.12389","volume":"17","author":"JM White","year":"2016","unstructured":"White, J. M. & Whittaker, G. R. Fusion of enveloped viruses in endosomes. Traffic 17, 593\u2013614 (2016).","journal-title":"Traffic"},{"key":"34111_CR35","doi-asserted-by":"publisher","first-page":"020421","DOI":"10.7189\/jogh.09.020421","volume":"9","author":"J Paget","year":"2019","unstructured":"Paget, J. et al. Global mortality associated with seasonal influenza epidemics: new burden estimates and predictors from the GLaMOR Project. J. Glob. Health 9, 020421 (2019).","journal-title":"J. Glob. Health"},{"key":"34111_CR36","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41579-018-0115-z","volume":"17","author":"JS Long","year":"2019","unstructured":"Long, J. S., Mistry, B., Haslam, S. M. & Barclay, W. S. Host and viral determinants of influenza A virus species specificity. Nat. Rev. Microbiol. 17, 67\u201381 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"34111_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07901-8","volume":"9","author":"KR Sanson","year":"2018","unstructured":"Sanson, K. R. et al. Optimized libraries for CRISPR-Cas9 genetic screens with multiple modalities. Nat. Commun. 9, 5416 (2018).","journal-title":"Nat. Commun."},{"key":"34111_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"34111_CR39","doi-asserted-by":"publisher","first-page":"12226","DOI":"10.1128\/JVI.02164-15","volume":"89","author":"BO Fulton","year":"2015","unstructured":"Fulton, B. O., Palese, P. & Heaton, N. S. Replication-competent influenza B reporter viruses as tools for screening antivirals and antibodies. J. Virol. 89, 12226\u201312231 (2015).","journal-title":"J. Virol."},{"key":"34111_CR40","doi-asserted-by":"publisher","first-page":"9247","DOI":"10.1074\/jbc.M807517200","volume":"284","author":"Y Kizuka","year":"2009","unstructured":"Kizuka, Y., Tonoyama, Y. & Oka, S. Distinct transport and intracellular activities of two GlcAT-P isoforms. J. Biol. Chem. 284, 9247\u20139256 (2009).","journal-title":"J. Biol. Chem."},{"key":"34111_CR41","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1750-2659.2008.00051.x","volume":"2","author":"U Kumlin","year":"2008","unstructured":"Kumlin, U., Olofsson, S., Dimock, K. & Arnberg, N. Sialic acid tissue distribution and influenza virus tropism. Influenza Other Respir. Viruses 2, 147\u2013154 (2008).","journal-title":"Influenza Other Respir. Viruses"},{"key":"34111_CR42","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/nrmicro3346","volume":"12","author":"JE Stencel-Baerenwald","year":"2014","unstructured":"Stencel-Baerenwald, J. E., Reiss, K., Reiter, D. M., Stehle, T. & Dermody, T. S. The sweet spot: defining virus-sialic acid interactions. Nat. Rev. Microbiol. 12, 739\u2013749 (2014).","journal-title":"Nat. Rev. Microbiol"},{"key":"34111_CR43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1154315","volume":"320","author":"RM Anthony","year":"2008","unstructured":"Anthony, R. M. et al. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 320, 373\u2013376 (2008).","journal-title":"Science"},{"key":"34111_CR44","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/S0300-9084(01)01312-8","volume":"83","author":"AS Opat","year":"2001","unstructured":"Opat, A. S., van Vliet, C. & Gleeson, P. A. Trafficking and localisation of resident Golgi glycosylation enzymes. Biochimie 83, 763\u2013773 (2001).","journal-title":"Biochimie"},{"key":"34111_CR45","doi-asserted-by":"publisher","first-page":"100354","DOI":"10.1016\/j.jbc.2021.100354","volume":"296","author":"M Kitano","year":"2021","unstructured":"Kitano, M. et al. Rab11-mediated post-Golgi transport of the sialyltransferase ST3GAL4 suggests a new mechanism for regulating glycosylation. J. Biol. Chem. 296, 100354 (2021).","journal-title":"J. Biol. Chem."},{"key":"34111_CR46","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1073\/pnas.1524498113","volume":"113","author":"J Baggen","year":"2016","unstructured":"Baggen, J. et al. Enterovirus D68 receptor requirements unveiled by haploid genetics. Proc. Natl Acad. Sci. USA 113, 1399\u20131404 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34111_CR47","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.1016\/S1473-3099(15)00543-5","volume":"16","author":"CC Holm-Hansen","year":"2016","unstructured":"Holm-Hansen, C. C., Midgley, S. E. & Fischer, T. K. Global emergence of enterovirus D68: a systematic review. Lancet Infect. Dis. 16, e64\u2013e75 (2016).","journal-title":"Lancet Infect. Dis."},{"key":"34111_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1006\/viro.2000.0324","volume":"271","author":"TA Martino","year":"2000","unstructured":"Martino, T. A. et al. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus. Virology 271, 99\u2013108 (2000).","journal-title":"Virology"},{"key":"34111_CR49","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/sj.gt.3302895","volume":"14","author":"J Palomeque","year":"2007","unstructured":"Palomeque, J. et al. Efficiency of eight different AAV serotypes in transducing rat myocardium in vivo. Gene Ther. 14, 989\u2013997 (2007).","journal-title":"Gene Ther."},{"key":"34111_CR50","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1038\/sj.mt.6300227","volume":"15","author":"S Reimsnider","year":"2007","unstructured":"Reimsnider, S., Manfredsson, F. P., Muzyczka, N. & Mandel, R. J. Time course of transgene expression after intrastriatal pseudotyped rAAV2\/1, rAAV2\/2, rAAV2\/5, and rAAV2\/8 transduction in the rat. Mol. Ther. 15, 1504\u20131511 (2007).","journal-title":"Mol. Ther."},{"key":"34111_CR51","doi-asserted-by":"publisher","first-page":"670","DOI":"10.3389\/fimmu.2020.00670","volume":"11","author":"G Ronzitti","year":"2020","unstructured":"Ronzitti, G., Gross, D. A. & Mingozzi, F. Human immune responses to adeno-associated virus (AAV) vectors. Front. Immunol. 11, 670 (2020).","journal-title":"Front. Immunol."},{"key":"34111_CR52","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.omtm.2019.12.008","volume":"17","author":"AT Martino","year":"2020","unstructured":"Martino, A. T. & Markusic, D. M. Immune response mechanisms against AAV vectors in animal models. Mol. Ther. Methods Clin. Dev. 17, 198\u2013208 (2020).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"34111_CR53","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41587-021-00822-w","volume":"39","author":"EL Blanchard","year":"2021","unstructured":"Blanchard, E. L. et al. Treatment of influenza and SARS-CoV-2 infections via mRNA-encoded Cas13a in rodents. Nat. Biotechnol. 39, 717\u2013726 (2021).","journal-title":"Nat. Biotechnol."},{"key":"34111_CR54","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41587-020-0692-z","volume":"38","author":"C Shaffer","year":"2020","unstructured":"Shaffer, C. Mist begins to clear for lung delivery of RNA. Nat. Biotechnol. 38, 1110\u20131112 (2020).","journal-title":"Nat. Biotechnol."},{"key":"34111_CR55","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.cell.2017.10.025","volume":"171","author":"HK Liao","year":"2017","unstructured":"Liao, H. K. et al. In vivo target gene activation via CRISPR\/Cas9-mediated trans-epigenetic modulation. Cell 171, 1495\u20131507.e1415 (2017).","journal-title":"Cell"},{"key":"34111_CR56","doi-asserted-by":"publisher","first-page":"101198","DOI":"10.1016\/j.coviro.2021.12.014","volume":"53","author":"JD Trimarco","year":"2022","unstructured":"Trimarco, J. D. & Heaton, N. S. From high-throughput to therapeutic: host-directed interventions against influenza viruses. Curr. Opin. Virol. 53, 101198 (2022).","journal-title":"Curr. Opin. Virol."},{"key":"34111_CR57","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1093\/infdis\/jis622","volume":"206","author":"RB Moss","year":"2012","unstructured":"Moss, R. B. et al. A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection. J. Infect. Dis. 206, 1844\u20131851 (2012).","journal-title":"J. Infect. Dis."},{"key":"34111_CR58","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/j.cell.2020.04.020","volume":"181","author":"TR Abbott","year":"2020","unstructured":"Abbott, T. R. et al. Development of CRISPR as an antiviral strategy to combat SARS-CoV-2 and influenza. Cell 181, 865\u2013876.e812 (2020).","journal-title":"Cell"},{"key":"34111_CR59","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.acthis.2019.06.004","volume":"121","author":"MF Martins","year":"2019","unstructured":"Martins, M. F., Honorio-Ferreira, A., Martins, P. & Goncalves, C. A. Presence of sialic acids in bronchioloalveolar cells and identification and quantification of N-acetylneuraminic and N-glycolylneuraminic acids in the lung. Acta Histochem. 121, 712\u2013717 (2019).","journal-title":"Acta Histochem."},{"key":"34111_CR60","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/1743-422X-10-321","volume":"10","author":"M Cohen","year":"2013","unstructured":"Cohen, M. et al. Influenza A penetrates host mucus by cleaving sialic acids with neuraminidase. Virol. J. 10, 321 (2013).","journal-title":"Virol. J."},{"key":"34111_CR61","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1016\/j.bbagen.2017.06.025","volume":"1861","author":"J Morise","year":"2017","unstructured":"Morise, J., Takematsu, H. & Oka, S. The role of human natural killer-1 (HNK-1) carbohydrate in neuronal plasticity and disease. Biochim. Biophys. Acta Gen. Subj. 1861, 2455\u20132461 (2017).","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"34111_CR62","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.3389\/fimmu.2018.01869","volume":"9","author":"AM Abel","year":"2018","unstructured":"Abel, A. M., Yang, C., Thakar, M. S. & Malarkannan, S. Natural killer cells: development, maturation, and clinical utilization. Front. Immunol. 9, 1869 (2018).","journal-title":"Front. Immunol."},{"key":"34111_CR63","doi-asserted-by":"publisher","first-page":"2681","DOI":"10.1073\/pnas.1809667116","volume":"116","author":"RJG Hulswit","year":"2019","unstructured":"Hulswit, R. J. G. et al. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via a conserved receptor-binding site in spike protein domain A. Proc. Natl Acad. Sci. USA 116, 2681\u20132690 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"34111_CR64","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1093\/glycob\/cwr112","volume":"22","author":"IV Alymova","year":"2012","unstructured":"Alymova, I. V. et al. Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin-neuraminidase glycoprotein. Glycobiology 22, 174\u2013180 (2012).","journal-title":"Glycobiology"},{"key":"34111_CR65","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1016\/j.febslet.2015.03.036","volume":"589","author":"K Fukushima","year":"2015","unstructured":"Fukushima, K. et al. Amino acid substitutions contributing to alpha2,6-sialic acid linkage binding specificity of human parainfluenza virus type 3 hemagglutinin-neuraminidase. FEBS Lett. 589, 1278\u20131282 (2015).","journal-title":"FEBS Lett."},{"key":"34111_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-58559-6","volume":"10","author":"RE Forgione","year":"2020","unstructured":"Forgione, R. E. et al. Structural basis for Glycan-receptor binding by mumps virus hemagglutinin-neuraminidase. Sci. Rep. 10, 1589 (2020).","journal-title":"Sci. Rep."},{"key":"34111_CR67","doi-asserted-by":"publisher","unstructured":"Dumm, R. E. & Heaton, N. S. The development and use of reporter influenza B viruses. Viruses 11, https:\/\/doi.org\/10.3390\/v11080736 (2019).","DOI":"10.3390\/v11080736"},{"key":"34111_CR68","doi-asserted-by":"publisher","first-page":"5098","DOI":"10.1128\/JVI.00170-16","volume":"90","author":"S Morosky","year":"2016","unstructured":"Morosky, S., Lennemann, N. J. & Coyne, C. B. BPIFB6 regulates secretory pathway trafficking and enterovirus replication. J. Virol. 90, 5098\u20135107 (2016).","journal-title":"J. Virol."},{"key":"34111_CR69","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S1386-6532(03)00004-0","volume":"26","author":"MS Oberste","year":"2003","unstructured":"Oberste, M. S., Nix, W. A., Maher, K. & Pallansch, M. A. Improved molecular identification of enteroviruses by RT-PCR and amplicon sequencing. J. Clin. Virol. 26, 375\u2013377 (2003).","journal-title":"J. Clin. Virol."},{"key":"34111_CR70","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/978-1-62703-125-7_9","volume":"945","author":"Y You","year":"2013","unstructured":"You, Y. & Brody, S. L. Culture and differentiation of mouse tracheal epithelial cells. Methods Mol. Biol. 945, 123\u2013143 (2013).","journal-title":"Methods Mol. Biol."},{"key":"34111_CR71","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.celrep.2016.05.074","volume":"15","author":"G Savidis","year":"2016","unstructured":"Savidis, G. et al. The IFITMs inhibit Zika virus replication. Cell Rep. 15, 2323\u20132330 (2016).","journal-title":"Cell Rep."},{"key":"34111_CR72","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0008-6215(00)84101-4","volume":"42","author":"M Curvall","year":"1975","unstructured":"Curvall, M., Lindberg, B. & Lonngren Structural studies of the capsular polysaccharide of Klebsiella type 81. Carbohydr. Res. 42, 73\u201382 (1975).","journal-title":"Carbohydr. Res."},{"key":"34111_CR73","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1099\/mic.0.066639-0","volume":"159","author":"J Santander","year":"2013","unstructured":"Santander, J. et al. Mechanisms of intrinsic resistance to antimicrobial peptides of Edwardsiella ictaluri and its influence on fish gut inflammation and virulence. Microbiology 159, 1471\u20131486 (2013).","journal-title":"Microbiology"},{"key":"34111_CR74","unstructured":"Simpson, S. & George, O. AAV production for serotypes with heparin binding capabilities., <https:\/\/www.protocols.io\/view\/aav-production-for-serotypes-with-heparin-binding-82zhyf6> (2020)."},{"key":"34111_CR75","doi-asserted-by":"publisher","unstructured":"McClure, C., Cole, K. L., Wulff, P., Klugmann, M. & Murray, A. J. Production and titering of recombinant adeno-associated viral vectors. J. Vis. Exp., e3348, https:\/\/doi.org\/10.3791\/3348 (2011).","DOI":"10.3791\/3348"},{"key":"34111_CR76","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1016\/j.str.2012.05.004","volume":"20","author":"TF Lerch","year":"2012","unstructured":"Lerch, T. F. et al. Structure of AAV-DJ, a retargeted gene therapy vector: cryo-electron microscopy at 4.5 A resolution. Structure 20, 1310\u20131320 (2012).","journal-title":"Structure"},{"key":"34111_CR77","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1089\/hgtb.2011.034","volume":"23","author":"C Aurnhammer","year":"2012","unstructured":"Aurnhammer, C. et al. Universal real-time PCR for the detection and quantification of adeno-associated virus serotype 2-derived inverted terminal repeat sequences. Hum. Gene Ther. Methods 23, 18\u201328 (2012).","journal-title":"Hum. Gene Ther. Methods"},{"key":"34111_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-017-0365-2","volume":"17","author":"LA Santry","year":"2017","unstructured":"Santry, L. A. et al. AAV vector distribution in the mouse respiratory tract following four different methods of administration. BMC Biotechnol. 17, 43 (2017).","journal-title":"BMC Biotechnol."},{"key":"34111_CR79","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1128\/JVI.74.3.1524-1532.2000","volume":"74","author":"CL Halbert","year":"2000","unstructured":"Halbert, C. L., Rutledge, E. A., Allen, J. M., Russell, D. W. & Miller, A. D. Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J. Virol. 74, 1524\u20131532 (2000).","journal-title":"J. Virol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34111-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34111-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34111-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T10:05:00Z","timestamp":1667124300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-34111-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,29]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["34111"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-34111-0","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,29]]},"assertion":[{"value":"4 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6456"}}